Boston Scientific (BSX) had planned to take its fast-growing endosurgery group public to raise as much as $1 billion. According to The Associated Press: "The endosurgery unit has recently enjoyed strong growth,…
Douglas A. McIntyre According to Reuters, net income at Toyota (TM) rose sharply on strong US and European sales. Reuters writes that American Home Mortgage (AHM) will close today and lay-off all of its employees.…
Amgen (AMGN) actually rallied a bit after hours yesterday. But, revenue growth was hard to come by. Amgen reported net income of $1.02 billion, or 90 cents per share, for the quarter…
A large drop in the sale of drug coated stents knocked Boston Scientific’s (BSX) quarter way down. The company’s second-quarter profit, excluding charges, was $271 million, or 18 cents per share, compared…
Douglas A. McIntyre Boston Scienfitic (BSX) has a deal to "settle all pending federal lawsuits against the company alleging harm from faulty defibrillators and pacemakers for $195 million," according to The Wall Street Journal. It…
Douglas A. McIntyre THURSDAYAdvanced Micro Devices (NYSDAQ:AMD)Ameritrade (NASDAQ:AMTD)Bank of America (NYSE:BAC)Bank of New York (NYSE:BK)Cemex (NYSE:CX/ADR)Continental Airlines (NYSE:CAL)Cypress Semi (NYSE:CY)Dow Jones (NYSE:DJ)Fifth Third Bancorp (NASDAQ:FITB)First Data (NYSE:FDC)Gilead Sciences (NASDAQ:GILD)Google (NASDAQ:GOOG)Harley-Davidson (NYSE:HOG)Honeywelll (NYSE:HON)Illinois Tool Works (NYSE:ITW)International…
According to Reuters, Australia Australian fund manager Caledonia said it would vote against Chicago Merch’s (CME) proposal to buy CBOT (CBOT) The fund own over 6% off the exchange. Reuters writes that…
As you will see, the short interest changes in medical and drug stocks of the active NYSE-listed names was a bit of a mixed bag. GlaxoSmithkline (GSK) saw the lagest increase, but…
Some sectors showed mixed results in the short selling, but the Big Pharma and medical instruments and related companies saw an increased activity in short selling in May versus April. Below is…